(S)-N-(((R)-5-((S)-3-(dimethylamino)pyrrolidin-1-yl)-1,2,3,4-tetrahydroisoquinolin-3-yl)methyl)-N-methyl-5,6,7,8-tetrahydroquinolin-8-amine

ID: ALA4877757

PubChem CID: 146398367

Max Phase: Preclinical

Molecular Formula: C26H37N5

Molecular Weight: 419.62

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CN(C)[C@@H]1CCN(c2cccc3c2C[C@H](CN(C)[C@H]2CCCc4cccnc42)NC3)C1

Standard InChI:  InChI=1S/C26H37N5/c1-29(2)22-12-14-31(18-22)24-10-5-8-20-16-28-21(15-23(20)24)17-30(3)25-11-4-7-19-9-6-13-27-26(19)25/h5-6,8-10,13,21-22,25,28H,4,7,11-12,14-18H2,1-3H3/t21-,22-,25+/m1/s1

Standard InChI Key:  ADYXBCCUUZUBGE-RQTOMXEWSA-N

Molfile:  

 
     RDKit          2D

 31 35  0  0  0  0  0  0  0  0999 V2000
   26.5821  -20.8961    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.5809  -21.7157    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.2890  -22.1246    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   27.2872  -20.4873    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.9958  -20.8925    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.9946  -21.7177    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.7047  -22.1290    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.4205  -21.7198    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.4217  -20.8946    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.7071  -20.4787    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.7024  -22.9462    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   27.9935  -23.3528    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.9912  -24.1700    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.2813  -24.5745    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   27.2771  -25.3881    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.6984  -24.5774    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.6924  -25.3972    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.9817  -25.8006    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.9767  -26.6159    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.6817  -27.0288    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.3932  -26.6204    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.3947  -25.8064    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.1036  -25.3999    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   29.4090  -23.3568    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.8458  -25.7319    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.3944  -25.1262    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.9879  -24.4172    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.1881  -24.5849    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.3224  -23.6716    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   32.1353  -23.5885    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.8440  -23.0091    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  5 10  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  7 11  1  6
 11 12  1  0
 13 12  1  1
 13 14  1  0
 13 16  1  0
 14 15  1  0
 15 18  1  0
 17 16  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 17  1  0
 22 23  1  0
 11 24  1  0
 23 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 23  1  0
 27 29  1  6
 29 30  1  0
 29 31  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4877757

    ---

Associated Targets(Human)

CXCR4 Tclin C-X-C chemokine receptor type 4 (3338 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2D6 Tclin Cytochrome P450 2D6 (33882 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP3A4 Tclin Cytochrome P450 3A4 (53859 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 419.62Molecular Weight (Monoisotopic): 419.3049AlogP: 3.25#Rotatable Bonds: 5
Polar Surface Area: 34.64Molecular Species: BASEHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 9.39CX LogP: 3.45CX LogD: 0.17
Aromatic Rings: 2Heavy Atoms: 31QED Weighted: 0.80Np Likeness Score: -0.65

References

1. Nguyen HH, Tahirovic YA, Truax VM, Wilson RJ, Jecs E, Miller EJ, Kim MB, Akins NS, Xu L, Jiang Y, Wang T, Sum CS, Cvijic ME, Schroeder GM, Wilson LJ, Liotta DC..  (2021)  Amino-Heterocycle Tetrahydroisoquinoline CXCR4 Antagonists with Improved ADME Profiles via Late-Stage Buchwald Couplings.,  12  (10.0): [PMID:34676043] [10.1021/acsmedchemlett.1c00449]

Source